|Articles|September 1, 2004

COX-2 inhibitors have potential for treating orbital disease

All patients demonstrated marked improvement of the redness, swelling, and inflammationassociated with thyroid orbitopathy.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Latest CME